We are live on
!
Find out more
TCM
Tanaka Capital Management Portfolio holdings
AUM
$59.9M
This Fund
S&P 500
This Quarter
Est. Return
+7.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$41.7M
AUM Growth
+$2.79M
(+7.2%)
Cap. Flow
+$2.37M
Cap. Flow
% of AUM
5.68%
Top 10 Holdings %
Top 10 Hldgs %
62.56%
Holding
55
New
3
Increased
4
Reduced
9
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$2.03M |
| 2 |
Tesla
TSLA
|
+$1.18M |
| 3 |
ADXS
Advaxis Inc
ADXS
|
+$1.12M |
| 4 |
GE Aerospace
GE
|
+$101K |
| 5 |
Applied Materials
AMAT
|
+$70.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$2.65M |
| 2 |
PARAA
Paramount Global Class A
PARAA
|
+$1.77M |
| 3 |
Opko Health
OPK
|
+$20.9K |
| 4 |
ATTU
Attunity Ltd
ATTU
|
+$16.9K |
| 5 |
CELG
Celgene Corp
CELG
|
+$3.25K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.67% |
| 2 | Healthcare | 20.17% |
| 3 | Technology | 18.98% |
| 4 | Communication Services | 10.94% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARAA
1
DELISTED
Paramount Global Class A
PARAA
| $4.13M | 9.91% |
75,490
-32,209
| -30% | -$1.77M |
|
|
2
Tesla
TSLA
$1.4T
| $3.83M | 9.18% |
281,640
+81,975
| +41% | +$1.18M |
|
3
Apple
AAPL
$4.67T
| $2.97M | 7.13% |
105,164
-120
| -0.1% | -$3.18K |
|
|
4
Ionis Pharmaceuticals
IONS
$9.65B
| $2.37M | 5.69% |
+64,770
| New | +$2.03M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $1.49M | 3.56% |
14,205
-30
| -0.2% | -$3.25K |
|
|
ATTU
6
DELISTED
Attunity Ltd
ATTU
| $1.46M | 3.49% |
219,273
-1,970
| -0.9% | -$16.9K |
|
7
Alaska Air
ALK
$4.69B
| $1.38M | 3.32% |
21,002
-33
| -0.2% | -$2.17K |
|
|
RTEC
8
DELISTED
Rudolph Technologies Inc
RTEC
| $1.32M | 3.17% |
74,469
+820
| +1% | +$13.9K |
|
|
9
Opko Health
OPK
$1.22B
| $1.25M | 3% |
118,123
-2,100
| -2% | -$20.9K |
|
10
Aflac
AFL
$58.8B
| $1.24M | 2.97% |
34,488
| – | – |
|
11
Qualcomm
QCOM
$180B
| $1.23M | 2.94% |
17,925
| – | – |
|
|
ADXS
12
DELISTED
Advaxis Inc
ADXS
| $1.11M | 2.65% |
+6,907
| New | +$1.12M |
|
|
13
GE Aerospace
GE
$350B
| $944K | 2.26% |
6,653
+678
| +11% | +$101K |
|
14
Honeywell
HON
$66.4B
| $891K | 2.14% |
8,508
-28
| -0.3% | -$2.93K |
|
15
JetBlue
JBLU
$1.75B
| $830K | 1.99% |
48,144
| – | – |
|
16
MacroGenics
MGNX
$280M
| $783K | 1.88% |
26,170
| – | – |
|
|
CPRX
17
DELISTED
Catalyst Pharmaceutical
CPRX
| $712K | 1.71% |
681,613
| – | – |
|
18
Helen of Troy
HELE
$661M
| $686K | 1.64% |
7,958
| – | – |
|
19
Onto Innovation
ONTO
$13.2B
| $642K | 1.54% |
28,727
| – | – |
|
20
Amgen
AMGN
$236B
| $559K | 1.34% |
3,353
-15
| -0.4% | -$2.54K |
|
21
Philip Morris
PM
$284B
| $532K | 1.28% |
5,475
| – | – |
|
|
SF
22
Stifel
SF
$12.3B
| $529K | 1.27% |
30,960
| – | – |
|
23
PepsiCo
PEP
$188B
| $351K | 0.84% |
3,226
| – | – |
|
24
Alphabet (Google) Class C
GOOG
$4.1T
| $279K | 0.67% |
7,040
| – | – |
|
25
Cameco
CCJ
$43.9B
| $235K | 0.56% |
27,415
| – | – |
|
Similar funds
GC
ACM
SCP
HPM
IPHI
RRC
MCMC
PAPAIJV
Tanaka Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Tanaka Capital Management held 55 positions worth $41.7M, up 7.2% from $38.9M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Tanaka Capital Management deployed $2.37M of net new capital in Q3 2016, opening 3 new positions and adding to 4 existing holdings. Its largest new stake was Ionis Pharmaceuticals: 64,770 shares worth $2.37M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Paramount Global Class A, an estimated $1.77M trimmed.
- Tanaka Capital Management's largest Q3 2016 buy was Ionis Pharmaceuticals: 64,770 shares worth $2.37M.
- Tanaka Capital Management added most to Tesla in Q3 2016, an estimated $1.18M increase.
- Tanaka Capital Management's biggest Q3 2016 reduction was Paramount Global Class A, cutting an estimated $1.77M.
- Tanaka Capital Management fully exited Gilead Sciences in Q3 2016, selling an estimated $2.65M.
- Tanaka Capital Management's ten largest holdings make up 63% of its $41.7M portfolio in Q3 2016.
- Tanaka Capital Management opened 3 new positions and closed 1 in Q3 2016.
- Tanaka Capital Management's portfolio value rose 7.2% quarter-over-quarter to $41.7M.
Based on Tanaka Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.